EBp is a CR manager distributing shares to instos & sop investors for a management fee. They’re trader, not a investor. I believe some greedy people decided keeping back some CR shares to trade on after market for quick profit. This is only way to explain why placement & SPP were heavily oversubscribed, but sold down heavily after market if no demand. They can sell up to 10% below the placement price, and still get their money back, because that what their management fee received from the company.
Similar practice they did when managed CR for other biotech, such as IMM, IMU etc. I remember IMM, IMU traded down up to 15% below CR price for a few months, followed by a spike up after a final dump, and good news afterward.
Believe it or not is up to you. I am not here to
hold your hands sorry. I am loading up some more @1.205 today. Cheers.
I am still hearing music - and getting louder, page-200
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.020(4.00%) |
Mkt cap ! $53.53M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 50.0¢ | 47.5¢ | $64.20K | 132.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 41187 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 10000 | 2 |
View Market Depth
| Last trade - 15.59pm 01/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |